Hemab
Copenhagen
About Hemab
Hemab is a company that creates preventative treatments for bleeding and thrombosis problems. The medicines developed by the business aggregate modify, balance, and at times recruit endogenous clotting components already present in the blood to the site of injury, allowing patients to produce hemostatic plugs or clots to avert life-threatening complications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $347.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Oct 2025)
- Website: hemab.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/hemab-31136 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.